Co-creator of the "cancer vaccine" Dr. Jacek Jemielity together with chemists and biochemists from his team and Polish immunologists founded ExploRNA Therapeutics, a spin-off of the University of Warsaw. The company aims to bring inventions of Polish RNA modification experts to the higher technological level.

In the future it will be possible to replace almost all human organs, which will contribute to our longevity. The first experiments involving the replacement of brain fragments are already being conducted, says cognitive scientists Prof. Włodzisław Duch.

Researchers from Warsaw have developed a way to create peptide nanocapsules, in which chemical reactions will take place. Such organic nanoreactors can facilitate production of compounds that are difficult to obtain.

Clinical Hospital No. 4 in Lublin launches a new, suplementary method of treating brain tumours, called NanoTherm. The treatment has the potential to extend the lives of patients. So far, this method has only been used in Germany.

The incidence of head and neck cancers dynamically increases in our country. These cancers are often detected at an advanced stage - Prof. Wojciech Golusiński from the Greater Poland Cancer Centre in Poznań alarmed during a meeting with journalists in Warsaw.

From the point of view of health, clock change always brings losses. Major sufferers are the sick, people with sleep disorders and children, says Dr. Michał Skalski from the Medical University of Warsaw, commenting on the EP`s decision to abolish daylight saving time.

Talks are ongoing with business partners regarding the implementation of an innovative test that detects bladder cancer, the University of Gdańsk reports. The university scientists from the Faculty of Chemistry of developed an effective, quick test that can be carried out at home.

A molecule that glows during the enzyme activity has been developed by Dr. Paulina Kasperkiewicz-Wasilewska from the Wrocław University of Science and Technology. Well known enzymes can be used for research on rapid cancer tests and targeted therapies.

Researchers from Łódź are investigating whether physiological low concentrations of ketone bodies, which are fat metabolism products, can alleviate the effects of diabetic vascular complications in patients with type 2 diabetes.